Skip to main content
. Author manuscript; available in PMC: 2019 Jun 15.
Published in final edited form as: Clin Cancer Res. 2018 Feb 2;24(12):2719–2731. doi: 10.1158/1078-0432.CCR-17-2494

Figure 1.

Figure 1

A flow diagram of precision oncology services that an individual patient may receive while being considered for a targeted agent or investigational therapy.

HHS Vulnerability Disclosure